2 Minute non-invasive screening for cardio-vascular diseases: Relative limitation of C-Reactive Protein compared with more sensitive L-homocystine as cardio-vascular risk factors; safe and effective treatment using the selective drug uptake enhancement method

Acupuncture and Electro-Therapeutics Research

Volumn 28, Issue 1-2, 2003, Pages 35-68

  Omura, Yoshiaki ^a   Shimotsuura, Yasuhiro ^a   Ohki, Motomu ^b  

^a ORT Life Science Research Institute ^*

^b ORT Life Science Research Institute   (Japan)

Author keywords

Bacterial infection; Bi Digital O Ring Test; C Reactive Protein (CRP); Cardio Vascular risk factors; Cilantro; EPA with DHA; Inflammation; L Homocyst(e)ine; Selective Drug Uptake Enhancement Method; Viral infection

Indexed keywords

BLOOD; DISEASES; LASER BEAMS;

CARDIO-VASCULAR DISEASES;

CARDIOLOGY;

AMOXICILLIN; ANTIVIRUS AGENT; C REACTIVE PROTEIN; CILANTRO EXTRACT; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; DOXYCYCLINE; FOLIC ACID; HOMOCYSTEINE; ICOSAPENTAENOIC ACID; INDIGO EXTRACT; INDIGO PLANT EXTRACT; OMEGA 3 FATTY ACID; PLANT EXTRACT; PYRIDOXINE; SHOSAIKOTO GO KEISHIKASHAKUYAKUTO; SUBSTANCE Z; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; ARTICLE; BI DIGITAL O RING TEST RESONANCE; BORRELIA INFECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE REPORT; CHLAMYDIASIS; CORIANDER; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG UPTAKE; HERPES; HUMAN; INDIGO PLANT; INFLAMMATION; LASER; LIVER DYSFUNCTION; MEDICINAL PLANT; NON INVASIVE MEASUREMENT; PLANT; RELIABILITY; RISK ASSESSMENT; RISK FACTOR; SAFETY; TUBERCULOSIS; VISUAL AID;

EID: 0042512454     PISSN: 03601293     EISSN: None     Source Type: Journal    
DOI: 10.3727/036012903815901741     Document Type: Article

References (122)

1. Gerritsen T, Vaughan JG, Waisman HA. The identification of homocysteine in the urine. Biochemistry and Biophysics Research Communication. 9:493-6, 1962.
2. Ratnoff OD. Activation of Hageman factor by L-homocystine. Science. 162(857):1007-9, 1968.
3. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology. 56:111-128, 1969.
4. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis. 22:215-27, 1975.
5. Omura Y, Nisteruk CJ, Losco M, Dreschnack P. Minute notches appearing in the QRS complexes of ECGs of humans and animals (following experimentally induced minute myocardial injuries), and their clinical significance and application for early diagnosis of myocardial abnormalities. Pp. 154-160 in Progress in Electrocardiology, ed. Peter W. Macfaralene, Medical Publications Division: Boston (Distributed by Year Book Medical Publishers, Inc., Chicago), 1979.
6. Graeber JE, Slott JH, Ulane RE, Schulman JD, Stuart MJ. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism. Pediatric Research. 16(6):490-3, 1982.
7. Reddy GS, Wilcken DE. Experimental homocysteinemia in pigs: comparison with studies in sixteen homocystinuric patients. Metabolism: Clinical & Experimental. 31(8):778-83, 1982.
8. Omura Y, Heller SI. Factors in the prevention of cardio-vascular diseases - Part 1: 96 cardio-vascular risk factors, with special emphasis on the prevention and treatment of hypertension, controllable dietary risk factors, and recommended U.S. dietary goals. Acupuncture & Electro-Therapeutics Research, The International Journal. 7:57-92, 1982.
9. de Groot PG, Willems C, Boers GH, Gonsalves MD, van Aken WG, van Mourik JA. Endothelial cell dysfunction in homocystinuria. European Journal of Clinical Investigation. 13(5):405-10, 1983.
10. Omura, Y. Electro-magnetic resonance phenomenon as a possible mechanism related to the "Bi-Digital O-Ring Test Molecular Identification and Localization Method." Acupuncture & Electrotherapeutics Research, The International Journal. 11:127-145, 1985.
11. Allen IC, Schousboe A, Griffiths R. Effect of L-homocysteine and derivatives on the high-affinity uptake of taurine and GABA into synaptosomes and cultured neurons and astrocytes. Neurochemical Research. 11 (11):1487-96, 1986.
12. Omura Y. Microbial infection or trauma at cardiovascular representation area of medulla oblongata as some of the possible causes of hypertension or hypotension. Acupuncture & Electro-Therapeutics Research, The International Journal. 13(2/3):131-145, 1988.
13. Omura Y, Losco M, Omura A, Takeshige C, Hisamitsu T, Nakajima H, Soejima K, Yamamoto S, Ishikawa H, Kagoshima T, Watari N, Shimotsuura Y, Matsubara T. Bi-directional transmission of molecular information by photon or electron beams passing in the close vicinity of specific molecules, and its clinical and basic research applications: 1) Diagnosis of humans or animal patients without any direct contact; 2) Light microscopic and electron microscopic localization of neuro-transmitters, heavy metals, Oncogen C-fos (AB2), etc. of intracellular fine structures of normal and abnormal single cells using light or electromicroscopic indirect Bi-Digital O-Ring Test. Acupuncture & Electro-Therapeutics Research, The International Journal. 17:29-46, 1992.
14. Wang J, Dudman NP, Wilcken DE, Lynch JF. Homocysteine catabolism: levels of 3 enzymes in cultured human vascular endothelium and their relevance to vascular disease. Atherosclerosis. 97(1):97-106, 1992.
15. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 41:715-722, 1992.
16. Stampfer, Meir J., et al. A prospective study of plasma homocyst(e)ine and risk of myocarial infarction in US physicians. Journal of the American Medical Association, 268(7):877-81, 1992.
17. Omura Y. Transmission of molecular information through electro-magnetic waves with different frequencies and its application to non-invasive diagnosis of patients as well as detection from patient's x-ray film of visible and not visible medical information: part I. Acupuncture & Electro-Therapeutics Research, The International Journal. 19(1):39-63, 1994.
18. Vanaerts LA, Blom HJ, Deabreu RA, Trijbels FJ, Eskes TK. Copius Peereboom-Stegeman JH, Noordhoek J. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology. 50(5):348-60, 1994.
19. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. Journal of the American Medical Association. 274:1049-57, 1995.
20. Omura Y, Lee AY, Beckman SL, Simon R, Lorberboym M, Duvvi H, Heller SI, Urich C. 177 cardiovascular risk factors, classified in 10 categories, to be considered in the prevention of cardiovascular diseases: An update of the original 1982 article containing 96 risk factors. Acupuncture & Electro-Therapeutics Research, The International Journal. 21:21-76, 1996.
21. McCully, K.S. Homocysteine and vascular disease. Nature Medicine 2:386-389, 1996.
22. Dudman, Nicholas P.B., et al. Human homocysteine catabolism: Three major pathways and their relevance to development of arterial occlusive disease. Journal of Nutrition, 126(4S):1295S-1300S, 1996.
23. Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: a population based study. American Journal of Epidemiology. 48:958-966, 1998.
24. Lalouschek W., Aull S., Deecke L., Schnider P., Uhl F., Zeiler K., Hyperhomocyst(e)inemia - an independent risk factor of stroke", Fortschritte der Neurologie, Psychiatrie. 64(7):271-7, 1996.
25. Mendall MA, Patel P, Ballam L, et al. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. British Medical Journal. 312:1061-1065, 1996.
26. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine. 336:973-979, 1997.
27. Alfthan, G., et al. Plasma Homocysteine and cardiovascular disease mortality. Lancet 349:397, 1997.
28. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arteriosclerosis, Thrombosis, and Vascular Biology. 17:1121-1127, 1997.
29. Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine. 337:230-6, 1997.
30. Trevisan M, Liu J, Bahsas FB, et al. Syndrome X and mortality: a population based study. American Journal of Epidemiology. 148:958-966, 1998.
31. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annual Review of Medicine. 49:31-62, 1988
32. Wilcken DE. Novel risk factors for vascular disease: the homocysteine hypothesis of cardiovascular disease. Journal Cardiovascular Risk. 5:217-21, 1988.
33. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia. 41:1241-1248, 1998.
34. Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation. 98:839-844, 1998.
35. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM. Diabetes Care. 21(5):841-8, 1998.
36. McCully KS. Homocysteine, folate, vitamin B6, and cardiovascular disease [editorial]. Journal of the American Medical Association. 279:392-393, 1998.
37. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes and its complications, part 1: diagnosis and classification of diabetes provisional report of a WHO consultation. Diabetic Medicine. 15:539-553, 1998.
38. Clarke R, Collins R. Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease. Journal of Cardiovascular Risk. 5:249-55, 1998.
39. Welch GN, Loscalzo J. Homocysteine and atherothrombosis. New England Journal of Medicine. 338:1042-1050, 1998.
40. Danesh J, Lewington S. Plasma homocysteine and coronary heart disease: systematic review of published epidemiological studies. Journal Cardiovascular Risk. 5:229-32, 1998.
41. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association [AHA Science Advisory]. Circulation. 99:178-182, 1999.
42. Ian Graham, FRCPI, FCCP, Homocysteine in Health and Disease, Annals of Internal Medicine, 131:387-388, 1999.
43. Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D'Agostino RB, Wolf PA, et al. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Archives of Internal Medicine. 159:1077-80, 1999.
44. McCully, K.S., The Homocysteine Revolution: Medicine for the New Millenium, McGraw-Hill Companies; June 1997, Revised January 1999.
45. Yudkin JS, Stehouwer CDA, Emeis JJ, et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role of cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology. 19:972-978, 1999.
46. Koenig W, Sund M, Froelich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring trends and determinants in cardiovascular disease) Augsberg Cohort Study, 1984 to 1992. Circulation. 99:237-242, 1999.
47. Fernandez-Real JM, Ricart W. Insulin resistance and inflammation in an evolutionary perspective: the contribution of cytokine genotype/phenotype to thriftiness. Diabetologia. 42:1367-1374, 1999.
48. Danesh J, Whincup P, Wlaker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. British Medical Journal. 321:199-204, 2000.
49. Hackam DG, Peterson JC, Spence JD. What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 μmol/L. American Journal of Hypertension. 13:105-110, 2000.
50. Festa A, D'Agostino R, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 102:42-47, 2000.
51. Frohlich M, Imhof A, Berg C, et al. Association between C-reactive protein and features of the metabolic syndrome: a population based study. Diabetes Care. 23:1835-1839, 2000.
52. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 102:2165-2168, 2000.
53. Vermeulen EG, Stehouwer CD, Twisk JW, van den Berg M, de Jong SC, Mackaay AJ, et al. Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet. 355:517-22, 2000.
54. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine 2000. 342:836-843, 2000.
55. Rasmussen, K., Moller, J. Total homocysteine measurement in clinical practice, Annals of Clinical Biochemistry; 37:3627-648, 2000
56. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 24:683-689, 2001.
57. Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein, interleukin 6, and the risk of developing type 2 diabetes mellitus. Journal of the American Medical Association. 286:327-334, 2001.
58. Ridker PM, Rifai N, Clearfield M, et al, for the Air Force/Texas Coronary Atherosclerosis Prevention Study Investigators. Measurement of C-reactive protein for the targeting of Statin therapy in the primary prevention of acute coronary events. New England Journal of Medicine. 344:1959-1965, 2001.
59. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. Journal of the American Medical Association. 285:2481-2485, 2001.
60. Pasceri V, Chang J, Willerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation. 103:2531-2534, 2001.
61. Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW. Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: implications for vascular disease. Circulation. 103(22):2717-23, 2001.
62. Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 51:1596-1600, 2002.
63. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol in the prediction of first cardiovascular events. New England Journal of Medicine. 347:1557-1565, 2002.
64. Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death. Diabetes. 51:1157-1165, 2002.
65. Festa A, D'Agostino R, Tracy RP, et al. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes. 51:1131-1137, 2002.
66. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. Journal of the American Medical Association. 287:356-359, 2002.
67. Centers for Disease Control/American Heart Association Workshop on Inflammatory Markers, and Cardiovascular Disease: application to clinical and public health practice: Atlanta, March 14-15, 2002. Atlanta, Ga: Centers for Disease Control and Prevention; 2002.
68. Pradhan A, Ridker PM. Do atherosclerosis and type 2 diabetes share a common inflammatory basis? European Heart Journal. 23:831-834, 2002.
69. Sato Y., Kaji M., Kondo I., Yoshida H., Satoh K., Metoki N., "Hyperhomocysteinemia in Japanese patients with convalescent stage ischemic stroke: effect of combined therapy with folic acid and mecobalamine", Journal of Neurological Science. 2002(1-2):65-8, 2002.
70. Ragone R., Homocystine Solubility and vascular disease", FASEB Journal. 16(3):401-4, 2002.
71. Mosca L. C-reactive protein-to screen or not to screen. New England Journal of Medicine. 347:1615-7, 2002.
72. Omura Y, Shimotsuura Y, Ohki M. 2 minute non-invasive screening of heart disease and 2 minute non-invasive screening of cardio-vascular diseases, and their safe and effective treatment. Acupuncture & Electro-Therapeutics Research, The International Journal. 27(3/4): 219-221, 2002.
73. Moller J, Ahola L, Abrahamsson L. Evaluation of the DPC IMMULITE 2000 assay for total homocysteine in plasma. [Journal Article] Scandinavian Journal of Clinical & Laboratory Investigation. 62(5):369-73, 2002.
74. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine. 347:1557-1565, 2002.
75. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. Journal of Internal Medicine. 252(4):283-294, 2002.
76. Mosca L. Novel cardiovascular risk factors: Do they add value to your practice? American Family Physician. 67:264-266, 2003.
77. Ridker PM. Clinical application of C Reactive Protein for cardiovascular disease detection and prevention. Circulation. 107(3):363-369, 2003.
78. Staff writer, Harvard University Gazette. C-reactive protein levels linked to health problems. Harvard University Gazette. Jan. 30, 2003.
79. Yeh E, Willerson JT. Coming of age of C-reactive protein: using inflammatory markers in cardiology. Circulation. 107(3):370-372, 2003.
80. Omura, Y., "Simple non-invasive methods of evaluating brain circulation, and the hypotensive and serum lipid lowering effects of acupuncture", pp. 449-459, Prophylactic Approach to Hypertensive Diseases: Perspectives in Cardiovascular Research: Volume 4, (Sponsored by NIH) ed. by Y. Yamori, W. Lovenberg, & E. D. Freis, Raven Press Books Ltd., N.Y.C., U.S.A., 1979.
81. Omura, Y., Nisteruk, C., Losco, Bro. M., Dreschnack, P., "Minute Notches and Slurring Appearing in the QRS Complexes of ECG's of Humans and Animals (Following Experimentally Induced Minute Myocardial Abnormalities)", pp. 154-160, Progress in Electrocardiology, ed. by P.W. Macfarlane, Pitman Medical Press, London, 1979 and G.K. Hall & Co., Boston, Mass., U.S.A., 1981.
82. Omura, Y., Editorial: Non-invasive circulatory evaluation and electro-acupuncture & TES treatment of diseases difficult to treat in Western medicine: 1) abnormal brain circulation and blood pressure: Cephalic Hypertension or Cephalic Hypotension Syndromes and their related conditions - headache, insomnia, blindness due to macular degeneration & retinitis pigmentosa, and some psychiatric problems; 2) severe lower extremity circulatory disturbances, with intractable pain, intermittent claudication, ulceration and/or severe diabetic neuropathy, Acupuncture & Electro-Therapeutics Research, The International Journal., Vol. 8: pp. 177-255, 1983.
83. Omura, Y., Nisteruk, C.J., Losco, Bro. M., Heller, S.I., Omura, A., Cook, A., Williams, G., Spence, D., Early non-invasive diagnosis of cardiovascular diseases using the "Bi-Digital O-Ring Test" and "Selective high-frequency wide band ECG's" in the presence or absence of abnormalities in standard ECG's, p. 176, in Abstracts of 10th International Congress on Electro-Cardiology and 24th International Symposium on Vectorcardiography, Bratislava, Czechoslovakia, August 16-19, 1983.
84. Omura, Y., Nisteruk, C., Losco, Bro. M., Heller, S., Omura, A., Cook, A., Spence, D., Williams, G., Loubser, P., The fine structures of the P-Wave, P-Q Interval and the QRS-Complex of the ECG, found by the use of selective high frequency wide bandwidth oscilloscopic ECG recordings, pp. 143-147 in Advances in Electrocardiology, ed. by P. D'Alche, Centre de Publications de l'Universite de Caen, France, 1985.
85. Omura, Y., Interrelationship between the heart and central nervous system: localization of neuro-transmitters and imaging of their associated nuclei, including the raphe nuclei & the locus coeruleus, as well as the imaging of the heart and its representation areas in slices of the human central nervous system using the "Bi-Digital O-Ring Test" imaging method, Acupuncture & Electro-Therapeutics Research, The International Journal., Vol. 12: pp. 139-170, 1987.
86. Omura, Y., Microbial infection or trauma at cardiovascular representation area of medulla oblongata as some of the possible causes of hypertension or hypotension, Acupuncture & Electro-Therapeutics Research. The International Journal., Vol. 13: pp. 131-145, 1988.
87. Omura, Y., Losco, Bro. M., Electro-magnetic fields in the home environment (color TV, computer monitor, microwave oven, cellular phone, etc.) as potential contributing factors for the induction of Oncogen C-fos Ab1, Oncogen C-fos Ab2, Integrin α5 β1 and development of cancer, as well as effects of microwave on amino acid composition of food and living human brain. Acupuncture & Electro-Therapeutics Research, The International Journal., Vol. 18, No. 1, pp. 33-73, 1993.
88. Butz LW, Vigneaud V. The formation of a homologue of cystine by the decomposition of methionine with sulfuric acid. Journal of Biological Chemistry, 99:135-142, 1932.
89. Du Vigneaud V, Dyer HM, Harmon J. The Growth-promoting properties of homocystine when added to a cystine-deficient diet and the proof of structure of homocystine. Journal of Biological Chemistry, 101:719-726, 1933.
90. Malinow MR, Bostom AG, Krauss RM, Homocyst(e)ine, Diet, and Cardiovascular Diseases: A Statement for Healthcare Professionals From the Nutrition Committee, American Heart Association, Circulation, 99:178-182, 1999.
91. Kasmussen K, Moller J, Total homocysteine measurement in clinical practice, Annals of Clinical Biochemistry, 37:627-648, 2000.
92. Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH, The Kideny and Homocysteine Metabolism, Journal of American Society of Nephrology, 12:2181-2189, 2001.
93. Mudd SH, Finkelstein JD, Refsum H, Ueland PM, Malinow MR, Lentz SR, Jacobsen DW, Brattswtrom L, Wilcken B, Wilcken D, Blom HJ, Stabler SP, Allen RH, Selhub J, Rosenberg IH, Homocysteine and Its Disulfide Derivatives: A suggested Consensus Terminology. Artherosclerosis, Thromobosis and Vascular Biology, 20:1704-1706, 2002.
94. Omura, Y., Storing of Qi Gong energy in various materials and drugs (Qi Gongnization): its clinical application for treatment of pain, circulatory disturbance, bacterial or viral infections, heavy metal deposits, and related intractable medical problems by selectively enhancing circulation and drug uptake, Acupuncture & Electro-Therapeutics Research, The International Journal., Vol 15:137-157, 1990.
95. Omura, Y., Simple non-invasive early detection and localization of specific cancer tissues of internal organs and differentiation of cancer tissue from surrounding areas infected by cancer related viruses, as well as evaluation of their micro-circulatory condition & drug uptake using the Bi-Digital O-Ring Test, Acupuncture & Electro-Therapeutics Research, The International Journal., Vol 15: No. 3 & 4, PP. 217-233, 1990.
96. Omura, Y., Losco, Bro. M., Omura, A.K., Takeshige, C., Hisamitsu, T., Shimotsuura, Y., Yamamoto, S., Ishikawa, H., Muteki, T., Nakajima, H., Urich, C., Common factors contributing to intractable pain and medical problems with insufficient drug uptake in areas to be treated, and their pathogenesis and treatment: Part I. Combined use of medication with acupuncture, (+) Qi Gong energy-stored material, soft laser or electrical stimulation, Acupuncture & Electro-Therapeutics Research, The International Journal., Vol 17: No.2, pp. 107-148, 1992.
97. Omura, Y., Simple non-invasive early detection and localization of specific cancer tissues of internal organs and differentiation of cancer tissue from surrounding areas infected by cancer related viruses, as well as evaluation of their micro-circulatory condition & drug uptake using Bi-Digital O-Ring Test. Program & Abstracts of 1st International Symposium on the Bi-Digital O-Ring Test organized by the Japan Bi-Digital O-Ring Test Assoc. and held at Waseda University, International Conference Center, Tokyo, Japan, pp. 63-64, May 7-9, 1993.
98. Omura, Y., Losco, M., Shimotsuura, Y., Takeshige, C., Causes & Effective Treatment of Intractable Pain using the Bi-Digital O-RIng Test & Various Drug Uptake Enhancement Methods (Acupuncture, (+) Qi Gong, etc.). Abstract, Third World Congress of the World Federation of Acupuncture, Kyoto, Japan, 1993.
99. Omura, Y., Quantitative Non-Invasive Estimation of Blood Glucose Level as well as Cholesterol and Uric Acid Levels Using Newly Discovered Bi-Digital O-Ring Extremely Weakening Phenomenon Between 2 Identical Substances of Identical Weight. Proceedings of the 4th Annual Japan Bi-Digital O-Ring Test Medical Society Symposium, pp. 9-10, held at the International Auditorium, Tokyo University, May 15-16, 1994.
100. Omura, Y., Accurate Localization of Organ Representation Areas on the Feet & Hands Using the Bi-Digital O-Ring Test Resonance Phenomenon: Its Clinical Implication in Diagnosis & Treatment- Part I. Acupuncture and Electro-Therapeutics Research: The International Journal. Vol. 19, Nos. 2 & 3, pp. 153-190, 1994.
101. Omura, Y., Beckman, S.L., Application of Intensified (+) Qi-Gong Energy, (-) Electrical Field, (S) Magnetic Field, Electrical Pulses (1-2 Pulses/sec), Strong Shiatsu Massage and/or Acupuncture on the Accurate Organ Representation Areas of the Hands to Improve Circulation and Enhance Drug Uptake in Pathological Organs: Clinical Applications with Special Emphasis on the "Chlamydia-(Lyme)-Uric Acid Syndrome" and "Chlamydia-(Cytomegalovirus)-Uric Acid Syndrome." Acupuncture & Electro-Therapuetics Research, The International Journal. Vol. 20, No. 1, pp.21-72, 1995.
102. Omura, Y., Effective Treatment of Intractable Medical Problems Using Accurate Organ Representation Areas of the Hand or the Cardiovascular Representations Area of the Medulla Oblongata Beneath the Occipital Area of the Skull with Drug Uptake Enhancement Methods Including Acupuncture, (+) Qi Gong, Shiatsu Massage, South Pole Magnetic Field, (-) Electrical Field and Others. Abstracts of the ICMART Symposium and 2nd Bulgarian Acupuncture Congress, p.1, held at the Hotel Vitosha, Sophia, Bulgaria, June 1-5, 1995.
103. Omura, Y., The Role of Environmental Electro-Magnetic Fields on the Genesis of Cancer and other Intractable Medical Problems & Drug Uptake Enhancement Using Electrical, Magnetic, or Electro-Magnetic Fields. Abstracts of the 2nd International Symposium on the Bi-Digital O-Ring Test, p.5, Showa University Medical School Auditorium, Tokyo, Japan, July 8-9, 1995.
104. Omura, Y. & Beckman, S., Role of Mercury (Hg) in Resistant Infections & Effective Treatment of Chlamydia Trachomatis and Herpes Family Viral Infections (and Potential Treatment for Cancer) by Removing Localized Hg Deposits with Chinese Parsley and Delivering Effective Antibiotics Using Various Drug Uptake Enhancement Methods. Acupuncture & Electro-Therapeutics research The International Journal, Vol. 20, Nos. 3 & 4, pp. 195-229, 1995.
105. Omura, Y., Early Cancer Screening and a New Safe and Effective Cancer Therapy Using Selective Drug Uptake Enhancement Methods, Anti-Viral Agents, and the Removal of Mercury Based on the Bi-Digital O-Ring Test Evaluation, 3rd International Symposium on the Bi-Digital O-Ring Test, pp. 127-128, Waseda University, Tokyo, Japan, 1997 Oct 3-5.
106. Omura, Y., Major Causes of Intractable Pain and their Effective Treatment Using the Bi-Digital O-Ring Test: Combined Use of Effective Anti-Microbial Agents, Cilantro to Remove Heavy Metals, and Drug Uptake Enhancement Method Selectively Deliver the Drugs to the Pathological Areas, 3rd International Symposium on the Bi-Digital O-Ring Test, pp. 147-148, Waseda University, Tokyo, Japan, 1997 Oct 3-5.
107. Omura, Y., Early Non-Invasive Cancer Screening by Detecting Levels of Integrin β5β1, Oncogene C-fos Ab-2, Hg, Acetylcholine, Viral Infection, NO, D-Glucose, p53 (Ab-5) & Rb (Ab-8), and a New Safe and Effective Cancer Therapy Using a Mixture of EPA & DHA as an Anti-Viral Agent, & Cilantro to Remove Intracellular Mercury and "Selective Drug Uptake Enhancement Method" Based on the Bi-Digital O-Ring Test Evaluation, 8th Congress of the Japan Bi-Digital O-Ring Test Medical Society, pp. 58-59, Showa University, Tokyo, Japan, 1998 Jul 19-20.
108. Omura, Y., Early Non-Invasive Cancer Screening by Detecting Levels of Integrin α5β1, Oncogene C-fos Ab-2, Hg, Acetycholine, Viral Infection, NO, D-Glucose, p53 (Ab-5) & Rb (Ab-8), and a New Safe and Effective Cancer Therapy Using a Mixture of EPA & DHA as an Anti-Viral Agent, & Cilantoro to Remove Intracellular Mercury and Selective Drug Uptake Enhancement Method Based on the Bi-Digital O-Ring Test Evaluation, Presented as a guest speaker at 8th Annual Congress of Japan Bi-Digital O-Ring Test Medical Society at Showa University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 23, No. 3 & 4, pp.229-230, 1998.
109. Omura, Y., Application of Bi-Digital O-Ring Test in the Evaluation of the Accuracy of Traditional Chinese Organ Representation Charts and for Non-invasive Diagnosis and Effective Treatment of Intractable Pain, Cancer, & Cardiovascular Problems using the Selective Drug Uptake Enhancement Method, Abstract of the 1st Spanish Inter-university Congress on Acupuncture (I Congreso Interuniversitario Espanol De Acupunctura), organized by 5 medical schools and the Spanish Government, published by the Faculty of Medicine, University of Zaragoza, Spain, pgs.93-96, Sept. 30-Oct. 3, 1999.
110. Omura, Y., Bi-Digital O-Ring Test: Its Application for the Diagnosis of Intractable Disease and Their Effective Treatment Using Selective Drug Uptake Enhancement Method (summary of plenary lecture in Japanese), Proceedings of the 4th Annual Symposium of Japan Alternative & Complementaiy Medicine Society, June 2000, pgs. 56-59.
111. Omura, Y., "Non-Invasive Diagnosis & Effective Treatment of Chronic Intractable Lower Back Pain Using the Bi-Digital O-Ring Test Resonance Phenomenon & The Selective Drug Uptake Enhancement Method," abstract published in Program and Abstract of the International Symposium: Satellite of the 9th Congress of the Pain Clinic, held in Tokyo, Japan, July 12-13, 2000, pgs. 66; the paper was subsequently published in the hardcover book Management of Pain: A World Perspective, ed. H. Yanagida, K. Hanaoka & O. Yuge, as part of the 9th International Symposium on Pain, organized by the International Association for the Study of Pain, by Monduzzi Editore, Bologna Italy, 2000, pgs. 65-74.
112. Omura, Y., Transmission of Molecular Information on Molecular Structures and Amounts of the Molecules Through the Recorded Traces of Photons, Sound Waves, and Electric Currents Coming Through Biological Tissue and Their Clinical Applications For New Non-invasive Diagnosis and Treatment of Intractable Medical Problems, presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pgs. 77-79, 2001.
113. Omura, Y., Abnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as one of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Field Hypersensitivity, Pre-Alzheimer's Disease, and Autism in Children and Their New effective Treatment by Removing These Metal Deposits Using Cilantro and the Selective Drug Uptake Enhancement Method (Part I), presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pgs. 102-104, 2001.
114. Omura, Y., Accurate Organ Representation Areas of the Face (Including Eyes, Nose, Lips, etc.), Tongue, Ear, Hands, Shu points & Mu points, and Feet Mapped Using the Bi-Digital O-Ring Test Resonance Phenomenon Between 2 Identical Tissues and Their Clinical Application for Diagnosis and Effective Treatment Using the Selective Drug Uptake Enhancement Method, presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, published in Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pg. 142, 2001.
115. Omura, Y., Transmission of Molecular Information on Molecular Structures and Amounts of the Molecules Through the Recorded Traces of Photons, Sound Waves, and Electric Currents Coming Through Biological Tissue and Their Clinical Applications For New Non-invasive Diagnosis and Treatment of Intractable Medical Problems, presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pgs. 77-79, 2001.
116. Omura, Y., Abnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as one of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Field Hypersensitivity, Pre-Alzheimer's Disease, and Autism in Children and Their New effective Treatment by Removing These Metal Deposits Using Cilantro and the Selective Drug Uptake Enhancement Method (Part I), presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pgs. 102-104, 2001.
117. Omura, Y., Accurate Organ Representation Areas of the Face (Including Eyes, Nose, Lips, etc.), Tongue, Ear, Hands, Shu points & Mu points, and Feet Mapped Using the Bi-Digital O-Ring Test Resonance Phenomenon Between 2 Identical Tissues and Their Clinical Application for Diagnosis and Effective Treatment Using the Selective Drug Uptake Enhancement Method, presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, published in Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pg. 142, 2001.
118. Omura, Y., Major Causes of Pre-Alzheimer's Disease, Autism, Etc. and Their Effective Treatment Using the Selective Drug Uptake Enhancement Method With (+) Qi-Gong Energy Stored Paper, abstract of the 1st World Symposium on Self-Healing & Consciousness Power, pg. 29, held June 8-10, 2001, at the Sheraton at Woodbridge, Iselin, New Jersey.
119. Omura, Y., Abnormal Deposits of Al, Pb, and Hg in the Brain, Particularly in the Hippocampus, as one of the Main Causes of Decreased Cerebral Acetylcholine, Electromagnetic Field Hypersensitivity, Pre-Alzheimer's Disease, and Autism in Children and Their New effective Treatment by Removing These Metal Deposits Using Cilantro and the Selective Drug Uptake Enhancement Method (Part I), presented at the 4th Biennial International Symposium on the Bi-Digital O-Ring Test, July 21-23, 2001, at Waseda University, Tokyo, Acupuncture & Electro-Therapeutics Research, The International Journal, Vol. 26, No. 1-2, pgs. 102-104, 2001.
120. Omura, Y., "Non-Invasive 6-Minute Screening of Pre-Alzheimer's Disease By Estimating Amounts of Acetylcholine, β-Amyloid (1-42), Al, Hg & Pb of the Brain, and the Safe & Effective Treatment of Pre-Alzheimer's Disease Using the "Selective Drug Uptake Enhancement Method", pgs. 75-76, Abstract of 5th Biennial International Symposium on Bi-Digital O-Ring Test, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002, reprinted in Acupuncture & Electro-Therapeutics Research, The International Journal Vol. 27, 3&4, 2002 (in press).
121. Omura, Y., "Non-Invasive 6-Minute Screening of Pre-Alzheimer's Disease By Estimating Amounts of Acetylcholine, β-Amyloid (1-42), Al, Hg & Pb of the Brain, and the Safe & Effective Treatment of Pre-Alzheimer's Disease Using the "Selective Drug Uptake Enhancement Method", pgs. 75-76, Abstract of 5th Biennial International Symposium on Bi-Digital O-Ring Test, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002, reprinted in Acupuncture & Electro-Therapeutics Research, The International Journal Vol. 27, 3&4, 2002 (in press).
122. Omura, Y., "2 Minute Screening of Cancer and Localization of the Cancer Using X-, Y-Axis Laser line Scanning of the Whole Body and Effective Treatment of Cancer using Selective Drug Uptake Enhancement Method Including Semi-Permanent Acupuncture on True St. 36, Which Markedly Reduces Cancer Cell Telomere and Enhances Normal Cell Telomere", pgs. 122-127, Abstract of 5th Biennial International Symposium on Bi-Digital O-Ring Test, organized and published by Japan Bi-Digital O-Ring Test Medical Society, held at Ibuka International Auditorium, Waseda University, Tokyo, Japan, during July 19-21, 2002.